Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 32601-32650 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06709833
Meningioma and Embolism Thrombosis Risk & Investigation of Coagulation
N/ARecruiting
100 participants
Started: Dec 16, 2024 · Completed: Aug 31, 2026
3 conditions1 sponsor1 location
NCT06812598
Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCT
NARecruiting
330 participants
Started: Dec 16, 2024 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06609044
Long-term Impact of NMDAR Encephalitis
N/ARecruiting
30 participants
Started: Dec 16, 2024 · Completed: Dec 17, 2025
1 condition1 sponsor1 location
NCT06409741
PrEveNtion of Biliary Events After Acute Pancreatitis in NonSUrgicaL PAtients: PENINSULA Trial
NAEnrolling by invitation
126 participants
Started: Dec 16, 2024 · Completed: Jul 31, 2027
2 conditions5 sponsors5 locations
NCT06439342
A Study of Maribavir in Chinese Adults With Cytomegalovirus (CMV) Infections
PHASE3Recruiting
20 participants
Started: Dec 16, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor12 locations
NCT06738758
Multicenter Real-World Cohort Study Evaluating the Impact of Early Intensive Lipid-Lowering Therapy on the Prognosis of Acute Coronary Syndrome Patients(ELITE-ACS)
N/ARecruiting
6,000 participants
Started: Dec 16, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06744452
"App-based Stress Management with the MHealth Application harmony"
NANot yet recruiting
154 participants
Started: Dec 16, 2024 · Completed: Feb 21, 2025
5 conditions1 sponsor1 location
NCT06732674
Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases
NARecruiting
218 participants
Started: Dec 16, 2024 · Completed: Feb 28, 2028
6 conditions3 sponsors1 location
NCT06742866
Efficacy and Safety of Intravenous + Oral Vs. Oral Amiodarone in Preventing Recurrence After Catheter Ablation in Patients with Persistent Atrial Fibrillation
NANot yet recruiting
418 participants
Started: Dec 16, 2024 · Completed: Jul 1, 2026
1 condition1 sponsor1 location
NCT06726954
Repetitive Transcranial Magnetic Stimulation Therapy in Spinal Cord Injury Related Neuropathic Pain
NARecruiting
63 participants
Started: Dec 16, 2024 · Completed: Sep 15, 2026
2 conditions1 sponsor1 location
NCT06737640
Evaluation of Clinical and Molecular Biomarkers in Immunotherapy Treatment in Gynecologic Cancer
N/ANot yet recruiting
90 participants
Started: Dec 16, 2024 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06738576
Allogeneic Use of Expanded Mesenchymal Stem Cells Derived From Adipose Tissue (HC106), Female Urinary Incontinence Women Over 50 Years Old
PHASE1Recruiting
60 participants
Started: Dec 16, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor6 locations
NCT06736912
This Study Aims to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties and Food Effect of IN-114199 in Healthy Participants
PHASE1Not yet recruiting
80 participants
Started: Dec 16, 2024 · Completed: Nov 11, 2025
1 condition1 sponsor1 location
NCT06735612
Respiratory Syncytial Virus Infection in Exacerbations of Chronic Obstructive Pulmonary Diasease: the RECODE Study
N/ARecruiting
892 participants
Started: Dec 16, 2024 · Completed: Sep 30, 2025
4 conditions1 sponsor1 location
NCT06742268
Extension Study on Safety and Rebound Effect of SAT-001 for Myopia in Children
N/ARecruiting
40 participants
Started: Dec 16, 2024 · Completed: Jul 30, 2026
1 condition1 sponsor5 locations
NCT05879276
Effect at 3 Months of Early Empagliflozin Initiation in Cardiogenic Shock Patients on Mortality, Rehospitalization, Left Ventricular Ejection Fraction and Renal Function.
PHASE3Recruiting
164 participants
Started: Dec 16, 2024 · Completed: Mar 16, 2027
1 condition1 sponsor8 locations
NCT06740539
Atrial Fibrillation with Heart Failure with Preserved Ejection Fraction: Treatment Strategies-Catheter Ablation Vs. Anti-Atrial Arrhythmia Drugs
NANot yet recruiting
304 participants
Started: Dec 16, 2024 · Completed: Jan 1, 2027
2 conditions5 sponsors1 location
NCT06772493
ViewFlex X ICE First-in-Human Study
N/ARecruiting
200 participants
Started: Dec 16, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor5 locations
NCT06744842
Effect of Genicular Nerve Block on Proprioception in Knee Osteoarthritis
NARecruiting
44 participants
Started: Dec 16, 2024 · Completed: Dec 15, 2026
1 condition1 sponsor1 location
NCT06741904
Non-invasive Methods for Predicting Decompensation of Chronic Liver Disease
N/AEnrolling by invitation
2,334 participants
Started: Dec 16, 2024 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT06750328
Outcomes of Isolated LCx Occlusion
N/ANot yet recruiting
50 participants
Started: Dec 16, 2024 · Completed: Nov 12, 2027
2 conditions1 sponsor0 locations
NCT06740981
Nutritional Intake in Patients on Noninvasive Ventilation: a Prospective Observational Study
N/ANot yet recruiting
126 participants
Started: Dec 16, 2024 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT06764589
Liquid Micro-biopsy: a Novel Approach to Study Tumor Microenvironment From the Peripheral Blood
N/AActive, not recruiting
90 participants
Started: Dec 16, 2024 · Completed: Dec 2, 2027
1 condition1 sponsor2 locations
NCT06832839
Study on the Mechanism of Cognitive Impairment in Patients with Moyamoya Disease
N/ARecruiting
360 participants
Started: Dec 16, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06750159
The Use of AKR1B10 for Monitoring Postoperative Recurrence of Hepatocellular Carcinoma
N/ANot yet recruiting
400 participants
Started: Dec 16, 2024 · Completed: Dec 31, 2029
1 condition1 sponsor0 locations
NCT07195773
Effects of rTMS on Corticomotor Excitability and Balance Performance in Parkinson's Disease
NARecruiting
24 participants
Started: Dec 16, 2024 · Completed: Oct 30, 2025
5 conditions1 sponsor1 location
NCT06745583
A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients
PHASE2Recruiting
15 participants
Started: Dec 16, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor2 locations
NCT06670937
Role of BARriers in IgG-Pathogen Interactions at the Mucosal Surface in Human Airways
NARecruiting
30 participants
Started: Dec 16, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06691113
A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal Polyps
PHASE2Recruiting
60 participants
Started: Dec 16, 2024 · Completed: Feb 9, 2027
1 condition2 sponsors56 locations
NCT06736522
Future Leaders Program: Testing a Youth Leadership, Engagement, and Mindfulness Program
NARecruiting
504 participants
Started: Dec 16, 2024 · Completed: Mar 31, 2028
2 conditions2 sponsors2 locations
NCT06903455
A Culturally Significant Cardiovascular Dance-based Intervention in Obese Women
NAEnrolling by invitation
22 participants
Started: Dec 16, 2024 · Completed: Jun 15, 2025
1 condition2 sponsors1 location
NCT06720090
Light Therapy for Obsessive-compulsive Disorder (OCD)
EARLY_PHASE1Recruiting
40 participants
Started: Dec 16, 2024 · Completed: Mar 31, 2029
1 condition1 sponsor1 location
NCT05548205
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
NARecruiting
150 participants
Started: Dec 16, 2024 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT06725849
Barriers to Physical Activity in Familial Mediterranean Fever
N/ANot yet recruiting
100 participants
Started: Dec 16, 2024 · Completed: Dec 16, 2025
1 condition1 sponsor1 location
NCT06920758
A 6-month, Randomized, Double-blind, Placebo Controlled Study Evaluating the Efficacy and Safety of USPlus DERM to Promote Hair Growth in Men and Women With Self-perceived Thinning Hair.
NAActive, not recruiting
60 participants
Started: Dec 16, 2024 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT06312644
Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
N/ARecruiting
75 participants
Started: Dec 16, 2024 · Completed: Jul 11, 2034
6 conditions1 sponsor8 locations
NCT06465147
REACT-01: Reversing Autoimmunity Through Cell Therapy
PHASE1Recruiting
12 participants
Started: Dec 16, 2024 · Completed: Oct 31, 2041
1 condition1 sponsor1 location
NCT06784193
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
PHASE1Recruiting
180 participants
Started: Dec 16, 2024 · Completed: Aug 30, 2027
6 conditions1 sponsor8 locations
NCT06003192
Screen Smart: Using Digital Health to Improve HIV Screening and Prevention
NARecruiting
63,000 participants
Started: Dec 16, 2024 · Completed: Mar 15, 2028
1 condition2 sponsors4 locations
NCT06548100
A Study of the Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD)
PHASE3Active, not recruiting
9 participants
Started: Dec 16, 2024 · Completed: Nov 3, 2026
1 condition1 sponsor2 locations
NCT06501625
Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Metastatic Cholangiocarcinoma With an IDH1 Mutation
PHASE1/PHASE2Recruiting
52 participants
Started: Dec 16, 2024 · Completed: Sep 13, 2027
1 condition1 sponsor28 locations
NCT06450041
NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
PHASE2Active, not recruiting
62 participants
Started: Dec 16, 2024 · Completed: Dec 31, 2038
1 condition4 sponsors13 locations
NCT06667076
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
PHASE2Recruiting
480 participants
Started: Dec 16, 2024 · Completed: Dec 26, 2030
1 condition1 sponsor143 locations
NCT06733441
A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma
PHASE1Recruiting
50 participants
Started: Dec 16, 2024 · Completed: Nov 15, 2028
1 condition1 sponsor5 locations
NCT06597747
Design Improvements With SONNET 3
NAActive, not recruiting
20 participants
Started: Dec 16, 2024 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT06747338
A Phase III Study of KN026 in Combination With HB1801 ± Carboplatin as Neoadjuvant Treatment for Early or Locally Advanced HER2-Positive Breast Cancer
PHASE3Recruiting
520 participants
Started: Dec 16, 2024 · Completed: Dec 16, 2027
1 condition1 sponsor1 location
NCT06317051
Optimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on Integrase Based Antiretroviral Therapy (ART)
PHASE3Recruiting
300 participants
Started: Dec 16, 2024 · Completed: Dec 31, 2026
2 conditions1 sponsor8 locations
NCT06732089
Digital Interventions for Adults with Treatment-Resistant Depression: a Pilot Study
N/ARecruiting
200 participants
Started: Dec 16, 2024 · Completed: Dec 31, 2026
3 conditions3 sponsors1 location
NCT06734351
A Study to Assess Safety and Effectiveness of Injections of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Change of Mid-Face Volume
PHASE3Recruiting
231 participants
Started: Dec 16, 2024 · Completed: Jul 31, 2029
1 condition1 sponsor4 locations
NCT06724640
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to Placebo in Adults Without HIV
PHASE1Recruiting
168 participants
Started: Dec 16, 2024 · Completed: Aug 16, 2028
1 condition1 sponsor1 location